AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

China HeadAche DIsorders RegiStry

Recruitingn/aAges 12 Years - anyAllBeijing Tiantan Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

It is planned to include 10000 patients. In the China HeadAche DIsorders RegiStry CHAIRS๏ผ‰, patients aged over 12 years with primary headache and medication-overuse headache(MOH) were collected. The biomarkers, imaging features, cognition, genetic characteristics, ocial and demographic data, medical data, therapeutics used, and outcome of headache-related diseases were studied, and long-term follow-up was planned.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Age โ‰ฅ 12 years old,Any gender; 2. The first onset age of primary headache was less than 50 years old(Age \<65 years at first diagnosis of chronic migraine); 3. patients with primary headache (migraine, tension headache and other types of primary headache) or primary headache complicated with MOH according to ICHD-3; 4. Sign the informed consent form. Exclusion Criteria: 1. According to the ICHD-3 diagnostic criteria, there are still headaches directly related to secondary factors (except drug overuse) at the time of enrollment; 2. Those who cannot be diagnosed as primary headache or primary headache combined with medication overuse headache according to ICHD-3; 3. According to DSM-V diagnostic criteria, patients with severe mental diseases (such as schizophrenia, mental disorders associated with mental retardation, etc.); 4. Patients with severe organic diseases, such as malignant tumors, and the expected survival time is less than 1 year; 5. Pregnant,planning pregnancy or Lactating women; 6. Subjects participating in other clinical trials; 7. Unable to cooperate to complete the follow-up due to geographical or other reasons
๐Ÿ’Š

What it tests

  • Medicine Overuse Headache/New Daily Persistent Headache
  • Episodic Migraine and Chronic Migraine
  • Patients with other types of primary headache
  • Yangxue Qingnao Granules (Pills)
  • Erenumab
๐Ÿ“

Where

61 sites
Anqing Municipal Hospital
Anqing, China
The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital)
Wuhu, China
Beijing Tiantan Hospital, Capital Medical University
Beijing, China
Beijing Chaoyang Hospital
Beijing, China
Peking University Third Hospital
Beijing, China
The First Hospital of Fangshan District, Beijing
Beijing, China
Chongqing People's Hospital
Chongqing, China
The Third Affiliated Hospital of Chongqing Medical University
Chongqing, China

โ€ฆand 53 more on ClinicalTrials.gov.

๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy